{
    "eid": "2-s2.0-85101029829",
    "title": "Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-Acting antiviral treatment a randomized, double-blind, placebo-controlled trial",
    "cover-date": "2021-02-09",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neuroscience (all)",
            "@code": "2800",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Biochemistry, Genetics and Molecular Biology (all)",
            "@code": "1300",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Agricultural and Biological Sciences (all)",
            "@code": "1100",
            "@abbrev": "AGRI"
        }
    ],
    "keywords": [
        "Direct-Acting agent",
        "Hepatitis C",
        "Liver fibrogenesis",
        "Liver fibrosis",
        "Vitamin D"
    ],
    "authors": [
        "Supachaya Sriphoosanaphan",
        "Kessarin Thanapirom",
        "Stephen J. Kerr",
        "Sirinporn Suksawatamnuay",
        "Panarat Thaimai",
        "Sukanya Sittisomwong",
        "Kanokwan Sonsiri",
        "Nunthiya Srisoonthorn",
        "Nicha Teeratorn",
        "Natthaporn Tanpowpong",
        "Bundit Chaopathomkul",
        "Sombat Treeprasertsuk",
        "Yong Poovorawan",
        "Piyawat Komolmit"
    ],
    "citedby-count": 3,
    "ref-count": 39,
    "ref-list": [
        "Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats",
        "Vitamin D deficiency 2.0: An update on the current status worldwide",
        "Vitamin D and the immune system",
        "Prevalence of vitamin D deficiency in chronic liver dis-ease",
        "25-Vitamin D levels in chronic hepatitis C infection: Association with cirrhosis and sustained virologic response",
        "Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients",
        "Vitamin D counteracts fibrogenic TGF-beta signalling in human hepatic stel-late cells both receptor-dependently and independently",
        "Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data",
        "A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response",
        "Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience",
        "Genomics and HCV infection: progression of fibrosis and treatment response",
        "EASL recommenda-tions on treatment of hepatitis C 2018",
        "Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-beta1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C",
        "Vitamin D: An innate antiviral agent suppressing hepatitis C virus in human hepatocytes",
        "Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivi-rals",
        "TGF-beta in blood: A complex problem",
        "Vitamin D deficiency",
        "Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline",
        "Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C",
        "Vitamin D deficiency in hepatitis C virus infection: what is old? what is new?",
        "Vitamin D supplementation improves serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: A randomized, double-blind, placebo-controlled study",
        "Changes in serum transforming growth factor-beta1 levels in chronic hepatitis C patients under antiviral therapy",
        "Vitamin D deficiency is associated with hepatic decompensation and inflammation in patients with liver cirrhosis: A prospective cohort study",
        "Liver fibrosis in HCV monoinfected and HIV/HCV coinfected patients: dysregulation of Ma-trix metalloproteinases (MMPs) and their tissue inhibitors timps and effect of HCV protease inhibitors",
        "Pathobiology of liver fibrosis: A translational success story",
        "Molecular serum markers of liver fibrosis",
        "Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology",
        "Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C",
        "Molecular mechanism of the reversibility of hepatic fibrosis: with special reference to the role of matrix metalloproteinases",
        "Morphometry confirms fibrosis regression from sustained virologic response to direct-Acting antivirals for hepatitis C",
        "Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection",
        "Magnitude and kinetics of decrease in liver stiffness after antiviral therapy in patients with chronic hepatitis C: A systematic review and meta-Analysis",
        "Changes in hepatic fibrosis and vitamin D levels after viral hepatitis C eradication using direct-Acting antiviral therapy",
        "The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013",
        "Hepatocellular carcinoma risk after direct-Acting antiviral therapy",
        "Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis",
        "The vitamin D receptor ag-onist, calcipotriol, modulates fibrogenic pathways mitigating liver fibrosis in-vivo: An experimental study",
        "Common and unique mechanisms regulate fibrosis in vari-ous fibroproliferative diseases"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Center of Excellence in Clinical Virology",
        "Ratchadaphiseksomphot Endowment Fund",
        "Ratchadapiseksompotch Fund",
        "National Science and Technology Development Agency",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}